Development of all-in-one CRISPR/Cas9 and CRISPRi AAV constructs to treat autosomal dominant retinitis pigmentosa
<p>Dominant mutations in RHO (rhodopsin) are the most common cause of autosomal dominant retinitis pigmentosa (RHO-adRP). RHO-adRP causes progressive loss of rod cells, followed by cone cells, leading to blindness. This disease is a candidate for CRISPR gene editing, as reduction of mutant rho...
第一著者: | Peddle, CF |
---|---|
その他の著者: | MacLaren, RE |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
2021
|
主題: |
類似資料
-
AAV-CRISPR/Cas9 Gene Editing Preserves Long-Term Vision in the P23H Rat Model of Autosomal Dominant Retinitis Pigmentosa
著者:: Saba Shahin, 等
出版事項: (2022-04-01) -
Genetic dissection of non-syndromic retinitis pigmentosa
著者:: Aarti Bhardwaj, 等
出版事項: (2022-01-01) -
Visual Acuity by Decade in 139 Males with RPGR-Associated Retinitis Pigmentosa
著者:: Samantha R. De Silva, DPhil, FRCOphth, 等
出版事項: (2024-03-01) -
Clinical and genetic features of Koreans with retinitis pigmentosa associated with mutations in rhodopsin
著者:: Young Hoon Jung, 等
出版事項: (2023-08-01) -
Stem cells set their sights on retinitis pigmentosa
著者:: Jeannette L Bennicelli, 等
出版事項: (2013-08-01)